You are here

  • Home
  • Archive
  • Volume 103, Issue 12
  • Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results

Article info

Article menu

Download PDFPDF

Clinical science
Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results

Authors

  • Rathika Kandasamy Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Marios Constantinou Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Sophie L Rogers Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Sukhpal Singh Sandhu Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Sanjeewa Wickremasinghe Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Salmaan Al-Qureshi Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Lyndell L Lim Department of Surgery (Ophthalmology), Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, East Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lyndell L Lim, Department of Surgery (Ophthalmology), Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia; limllp{at}unimelb.edu.au
View Full Text

Citation

Kandasamy R, Constantinou M, Rogers SL, et al
Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results
British Journal of Ophthalmology 2019;103:1753-1758.

Publication history

  • Received October 23, 2018
  • Revised January 31, 2019
  • Accepted January 31, 2019
  • First published February 28, 2019.
Online issue publication 
November 21, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.